| Literature DB >> 32334457 |
Essam E Ayad1, Yousra O Kamal Eldin2, Ali A El-Hindawi1, Mona S Abdelmagid1, Hesham A Elmeligy3.
Abstract
BACKGROUND: Colorectal cancer is one of the leading causes of cancer death in both developed and developing nations. It is the third most common type of cancer and the fourth leading cause of cancer-related deaths worldwide. Ezrin is involved in maintaining cell structure and cell motility. Expression levels of the ezrin gene correlate with numerous human malignancies.Entities:
Keywords: Colorectal carcinoma; Ezrin; digital pathology; immunohistochemical expression; quantitative analysis
Year: 2020 PMID: 32334457 PMCID: PMC7445977 DOI: 10.31557/APJCP.2020.21.4.967
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Relation between Immunohistochemical Expression of Ezrin and Different Clinicopathological Parameters when Analyzed by Objective Method of Analysis
| Ezrin expression (Objective analysis) | P value | |||||
|---|---|---|---|---|---|---|
| Negative | Weakly positive | Strongly positive | ||||
| Total (n/%) | N (%) | N (%) | N (%) | |||
| Gender | Male | [(25 (49)] | 2 (8) | 10 (40) | 13 (52) | 0.774 |
| Female | [(26 (51)] | 2 (7.7) | 8 (30.8) | 16 (61.5) | ||
| Tumor Grade | Grade II | [(44 (86.3)] | 4 (9.1) | 18 (40.9) | 22 (50) | 0.046 |
| Grade III | [(7 (13.7)] | 0 (0) | 0 (0) | 7 (100) | ||
| Tumor stage | Stage 2 | [(7 (13.7)] | 1 (14.3) | 5 (71.4) | 1 (14.3) | 0.154 |
| Stage 3 | [(37 (72.5)] | 2 (5.4) | 11 (29.7) | 24 (64.9) | ||
| Stage 4 | [(7 (13.7)] | 1 (14.3) | 2 (28.6) | 4 (57.1) | ||
| Lymph node Stage | Negative | [(26 (51)] | 3 (11.5) | 10 (38.5) | 13 (50) | 0.292 |
| Stage 1 | [(9 (17.6)] | 0 (0) | 5 (55.6) | 4 (44.4) | ||
| Stage 2 | [(16 (31.4)] | 1 (6.3) | 3 (18.8) | 12 (75) | ||
| Distant Metastasis | Negative | [(50 (98)] | 4 (8) | 18 (36) | 28 (56) | 0.679 |
| Positive | [(1 (2)] | 0 (0) | 0 (0) | 1 (100) | ||
| Lymph node Metastasis | Negative | [26 (51)] | 3 (11.5) | 10 (38.5) | 13 (50) | 0.469 |
| Positive | [(25 (49)] | 1 (4) | 8 (32) | 16 (64) | ||
| Tumor Site | Left side | [(11 (21.6)] | 2 (18.2) | 5 (45.5) | 4 (36.4) | 0.107 |
| Rectum | [(5 (9.8)] | 0 (0) | 2 (40) | 3 (60) | ||
| Right side | [(21 (41.2)] | 0 (0) | 4 (19) | 17 (81) | ||
| Sigmoid | [(10 (19.6)] | 1 (10) | 6 (60) | 3 (30) | ||
| Transverse colon | [(4 (7.8)] | 1 (25) | 1 (25) | 2 (50) | ||
| Gross appearance | Fungating | [(20 (39.2)] | 1 (5) | 9 (45) | 10 (50) | 0.418 |
| Infiltrating | [(10 (19.6)] | 1 (10) | 1 (10) | 8 (80) | ||
| Ulcer | [(21 (41.2)] | 2 (9) | 8 (38.1) | 11 (52.4) | ||
| Microscopic diagnosis | Adenocarcinoma | [(45 (88.2)] | 4 (8.9) | 17 (37.8) | 24 (53.3) | 0.735 |
| Mucinous | [(3 (5.9)] | 0 (0) | 0 (0) | 3 (100) | ||
| neuroendocrine | [(1 (2)] | 0 (0) | 0 (0) | 1 (100) | ||
| Papillary adenocarcinoma | [(2 (3.9)] | 0 (0) | 1 (50) | 1 (50) | ||
| Age category | Age category | [(5 (9.8)] | 0 (0) | 1 (20) | 4 (80) | 0.516 |
| > 40 years | [(46 (90.2] | 4 (8.7) | 17 (37) | 25 (54.3) | ||
| Tumor size category | ≤ 5 | [(28 (54.9)] | 2 (7.1) | 12 (42.9) | 14 (50) | 0.459 |
| > 5 | [(23 (45.1)] | 2 (8.7) | 6 (26) | 15 (65.2) | ||
Figure 3Moderately Differentiated Adenocarcinoma Showing Negative Ezrin Staining Intensity (IHC Staining x 100).
Figure 4Moderately Differentiated Adenocarcinoma Showing Weak Cytoplasmic Ezrin Staining Intensity (IHC Staining x 200).
Figure 5Moderately Differentiated Adenocarcinoma Showing Moderate Cytoplasmic Ezrin Staining Intensity (IHC Staining x 200).
Figure 6Mucinous Adenocarcinoma with Signet Ring Features Showing Strong Cytoplasmic Ezrin Staining Intensity (IHC Staining x 50).
Relation between Immunohistochemical Expression of Ezrin when Analyzed by Objective Method of Analysis and when Analyzed by Digital Quantitative Assessment
| Ezrin expression (Objective analysis) |
| ||||
|---|---|---|---|---|---|
| Negative | Weakly positive | Strongly positive | |||
| N (%) | N (%) | N (%) | |||
| Ezrin expression | Negative | 3 (100) | 0 (0) | 0 (0) | <0.001 |
| (Quantitative analysis) | Weakly positive | 1 (3.6) | 17 (60.7) | 10 (35.7) | |
| Strongly positive | 0 (0) | 1 (5) | 19 (95) | ||
Figure 1Illustrating the Relation between Ezrin IHC Expression Using Objective Analysis and Quantitative Analysis
Figure 2Illustrating the Correlation between Ezrin IHC Expression Objective Analysis and Ezrin IHC Expression Quantitative Analysis